Free Trial

Ginkgo Bioworks (DNA) News Today

→ Don’t make this retirement mistake (From Sasco Gold LLC) (Ad)
Free DNA Stock Alerts
$0.51
0.00 (0.00%)
(As of 06/10/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 9 at 3:19 AM | marketbeat.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Given Average Recommendation of "Reduce" by Analysts
Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the six research firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, two have given a
June 7 at 7:16 AM | americanbankingnews.com
Ginkgo Bioworks (NYSE:DNA) Shares Down 3.8%
June 5, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Trading Down 3.8%
Ginkgo Bioworks (NYSE:DNA) Trading Down 3.8%
June 3, 2024 | marketbeat.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Purchased by Lingotto Investment Management LLP
Lingotto Investment Management LLP lifted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 34.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,511,301 shares of the company'
June 3, 2024 | marketbeat.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Drop in Short Interest
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 274,440,000 shares, a decline of 5.3% from the April 30th total of 289,730,000 shares. Approximately 19.7% of the shares of the company are short sold. Based on an average daily volume of 38,130,000 shares, the days-to-cover ratio is presently 7.2 days.
June 2, 2024 | marketbeat.com
Norges Bank Makes New $24.97 Million Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Norges Bank purchased a new stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 14,773,078 shares of the company's stock, valued at approximately $24,967,000. Norges Ba
June 1, 2024 | americanbankingnews.com
Ginkgo Bioworks (NYSE:DNA) Shares Gap Up to $0.56
May 31, 2024 | americanbankingnews.com
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 5.6%
May 31, 2024 | investorplace.com
3 Sorry Biotech Stocks to Sell in May While You Still Can
May 31, 2024 | fool.com
Ginkgo Bioworks Stock: Bull vs. Bear
May 30, 2024 | fool.com
Should You Buy the Dip on Ginkgo Bioworks Stock?
May 29, 2024 | fool.com
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
May 28, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Hits New 52-Week Low at $0.61
Ginkgo Bioworks (NYSE:DNA) Reaches New 1-Year Low at $0.61
May 25, 2024 | finance.yahoo.com
3 Things You Need to Know if You Buy Ginkgo Bioworks Today
May 25, 2024 | fool.com
3 Things You Need to Know if You Buy Ginkgo Bioworks Today
May 25, 2024 | fool.com
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
May 23, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Sees Strong Trading Volume
Ginkgo Bioworks (NYSE:DNA) Sees Strong Trading Volume
May 22, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Hits New 52-Week Low at $0.69
Ginkgo Bioworks (NYSE:DNA) Hits New 12-Month Low at $0.69
May 21, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Shares Down 4.3% on Insider Selling
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 4.3% Following Insider Selling
May 21, 2024 | insidertrades.com
Marijn E. Dekkers Sells 265,000 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock
May 20, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Shares Gap Up to $0.81
Ginkgo Bioworks (NYSE:DNA) Shares Gap Up to $0.81
May 20, 2024 | fool.com
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
May 18, 2024 | fool.com
Is Ginkgo Bioworks Holdings Stock a Buy?
May 16, 2024 | fool.com
4 Small-Cap Value Stocks That Could Go Parabolic
May 16, 2024 | marketbeat.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 289,730,000 shares, a growth of 8.7% from the April 15th total of 266,530,000 shares. Approximately 20.8% of the company's shares are short sold. Based on an average trading volume of 30,860,000 shares, the short-interest ratio is presently 9.4 days.
May 15, 2024 | msn.com
Ginkgo slips as BTIG cuts to Sell on strategic shift
May 15, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 7.9% Following Analyst Downgrade
Ginkgo Bioworks (NYSE:DNA) Shares Down 7.9% on Analyst Downgrade
May 15, 2024 | marketbeat.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Given Average Rating of "Reduce" by Brokerages
Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) have earned a consensus recommendation of "Reduce" from the five analysts that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, one has assigned a hol
May 15, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $1.00 by Analysts at Morgan Stanley
Morgan Stanley cut their price objective on Ginkgo Bioworks from $2.00 to $1.00 and set an "equal weight" rating on the stock in a research report on Wednesday.
May 15, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Lowered to Sell at BTIG Research
BTIG Research lowered shares of Ginkgo Bioworks from a "neutral" rating to a "sell" rating in a research note on Wednesday.
May 15, 2024 | insidertrades.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Director Harry Sloan Purchases 297,619 Shares
May 15, 2024 | prnewswire.com
Ginkgo Bioworks to Participate in Two Conferences in May
May 14, 2024 | marketbeat.com
Insider Buying: Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Director Buys 297,619 Shares of Stock
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) Director Harry Sloan purchased 297,619 shares of the firm's stock in a transaction on Tuesday, May 14th. The stock was acquired at an average cost of $0.91 per share, for a total transaction of $270,833.29. Following the completion of the purchase, the director now owns 718,540 shares in the company, valued at approximately $653,871.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
May 14, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Trading 13.7% Higher
Ginkgo Bioworks (NYSE:DNA) Trading 13.7% Higher
May 14, 2024 | prnewswire.com
Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
May 13, 2024 | finance.yahoo.com
Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE
May 13, 2024 | seekingalpha.com
Ginkgo Bioworks: Massive Revenue Warning
May 11, 2024 | finance.yahoo.com
Ginkgo Bioworks Holdings First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 10, 2024 | bizjournals.com
Ginkgo to reduce headcount, physical footprint after disappointing Q1
May 10, 2024 | finance.yahoo.com
Ginkgo Bioworks Holdings Inc (DNA) Reports Q1 2024 Results: A Comprehensive Overview
May 10, 2024 | msn.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2024 Earnings Call Transcript
May 10, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Posts Earnings Results, Hits Estimates
Ginkgo Bioworks (NYSE:DNA - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.08). Ginkgo Bioworks had a negative net margin of 355.08% and a negative return on equity of 48.23%. The business had revenue of $37.94 million during the quarter, compared to analyst estimates of $45.50 million. During the same quarter in the previous year, the firm earned ($0.08) earnings per share.
May 10, 2024 | msn.com
Ginkgo Bioworks slips on guidance cut; William Blair downgrades
May 10, 2024 | marketbeat.com
Ginkgo Bioworks (NYSE:DNA) Lowered to "Underperform" at William Blair
William Blair lowered Ginkgo Bioworks from a "market perform" rating to an "underperform" rating in a research note on Friday.
May 9, 2024 | msn.com
Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change'
May 9, 2024 | seekingalpha.com
Ginkgo Bioworks Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 9, 2024 | prnewswire.com
Ginkgo Bioworks Reports First Quarter 2024 Financial Results
May 7, 2024 | investorplace.com
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now
May 7, 2024 | prnewswire.com
GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener
May 7, 2024 | insidertrades.com
Mark E. Dmytruk Sells 47,806 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock
Get Ginkgo Bioworks News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter.

DON’T buy gold until you read this (Ad)

If you're an American who understands that your money is rotting away as you read this email… Then this is for YOU. 99% of people are buying gold the wrong way.

Reserve your seat here.

DNA Media Mentions By Week

DNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DNA
News Sentiment
▼
0.51

0.76
▲
Average
Medical
News Sentiment

DNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DNA Articles
This Week
▼
4

5
▲
DNA Articles
Average Week

Get Ginkgo Bioworks News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:DNA) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Bill Clinton Backing Biden Replacement???
Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...
The Freeport Society | Sponsored
DON’T buy gold until you read this
If you're an American who understands that your money is rotting away as you read this email… Then this is ...
Sasco Gold LLC | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Hurry! Buy this stock before the Robinhood traders do!
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored